Welcome to Skilled in the Art. I’m Law.com IP reporter Scott Graham. Here’s what’s cracking this week.
- Could intellectual property actually help bridge U.S.-China tensions?
- The next big patent trial is coming soon to the Western District of Texas.
- Pfizer, BioNTech and Regeneron turn to Williams & Connolly, Paul Hastings and Latham & Watkins in COVID patent infringement cases.
Even China Has Questions About the Alice Test
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]